MacroGenics, Inc.
MGNX
$1.39
$0.1310.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 80.53% | 964.81% | -17.81% | -62.83% | -85.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 80.53% | 964.81% | -17.81% | -62.83% | -85.33% |
| Cost of Revenue | -6.60% | 26.64% | 80.30% | -2.53% | 0.15% |
| Gross Profit | 31.98% | 395.74% | -51.74% | -56.80% | -243.42% |
| SG&A Expenses | 121.42% | 13.66% | 5.34% | 8.74% | -8.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.17% | 23.13% | 18.73% | -0.11% | -1.70% |
| Operating Income | -7.06% | 252.64% | -29.40% | -39.88% | -511.87% |
| Income Before Tax | 68.58% | 220.78% | -196.86% | -37.31% | -459.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 66.53% | 220.78% | -196.86% | -37.31% | -459.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.53% | 220.78% | -196.86% | -37.31% | -459.88% |
| EBIT | -7.06% | 252.64% | -29.40% | -39.88% | -511.87% |
| EBITDA | -7.02% | 266.98% | -33.74% | -46.46% | -411.91% |
| EPS Basic | 66.93% | 216.88% | -195.65% | -36.25% | -457.02% |
| Normalized Basic EPS | -8.81% | 216.89% | -195.66% | -36.27% | -457.00% |
| EPS Diluted | 66.59% | 220.50% | -196.74% | -36.61% | -458.85% |
| Normalized Diluted EPS | -8.81% | 217.53% | -196.24% | -36.27% | -457.00% |
| Average Basic Shares Outstanding | 1.19% | 1.23% | 1.27% | 0.78% | 0.78% |
| Average Diluted Shares Outstanding | 1.19% | 1.00% | 0.65% | 0.78% | 0.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |